2022
Rare Tumors of the Bile Ducts
Campbell E, Jamidar P. Rare Tumors of the Bile Ducts. 2022, 347-361. DOI: 10.1007/978-3-030-41683-6_20.Peer-Reviewed Original ResearchBile ductTumor typesBenign biliary tumorsBile duct tumorsIntraductal papillary neoplasiaBile duct adenomaHepatic foregut cystSquamous cell carcinomaVon Meyenburg complexesGranular cell tumorSmall patient populationAdenomyomatous hyperplasiaBiliary tumorsDuct adenomaDuct tumorBiliary tractForegut cystMeyenburg complexesPathological examinationBiliary adenofibromaCell carcinomaPatient populationRare tumorPapillary neoplasiaTraumatic neuroma
2021
Rare Tumors of the Bile Ducts
Campbell E, Jamidar P. Rare Tumors of the Bile Ducts. 2021, 1-15. DOI: 10.1007/978-3-030-37482-2_20-1.Peer-Reviewed Original ResearchBile ductTumor typesBenign biliary tumorsBile duct tumorsIntraductal papillary neoplasiaBile duct adenomaHepatic foregut cystSquamous cell carcinomaVon Meyenburg complexesGranular cell tumorSmall patient populationAdenomyomatous hyperplasiaBiliary tumorsDuct adenomaDuct tumorBiliary tractForegut cystMeyenburg complexesPathological examinationBiliary adenofibromaCell carcinomaPatient populationRare tumorPapillary neoplasiaTraumatic neuroma
2019
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease
Malczewska A, Oberg K, Bodei L, Aslanian H, Lewczuk A, Filosso PL, Wójcik-Giertuga M, Rydel M, Zielińska-Leś I, Walter A, Suarez A, Kolasińska-Ćwikła A, Roffinella M, Jamidar P, Ziora D, Czyżewski D, Kos-Kudła B, Ćwikła J. NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease. Neuroendocrinology 2019, 108: 219-231. PMID: 30654372, PMCID: PMC7472425, DOI: 10.1159/000497037.Peer-Reviewed Original ResearchConceptsSmall cell lung cancerLarge cell neuroendocrine carcinomaSquamous cell carcinomaIdiopathic pulmonary fibrosisBronchopulmonary carcinoidsNETest levelsLung cancerAtypical carcinoidLiquid biopsyLung neuroendocrine tumorsRECIST 1.1Stable diseaseMetastatic diseaseProgressive diseaseStudy cohortClinical progressionPulmonary fibrosisCell carcinomaNeuroendocrine carcinomaNeuroendocrine tumorsLung neoplasiaHealthy controlsNeuroendocrine neoplasiaBlinded studyBlood samples